Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1995 3
1997 3
1999 4
2000 4
2001 2
2002 3
2003 4
2004 4
2005 5
2006 3
2007 2
2008 3
2009 1
2011 3
2012 2
2013 4
2014 4
2015 3
2016 2
2017 4
2018 4
2019 2
2020 4
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

PubMed (Weighted) Links for id: 12621909

71 results
Results by year
Filters applied: . Clear all
Page 1
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.
Wang J, Vuitton DA, Müller N, Hemphill A, Spiliotis M, Blagosklonov O, Grandgirard D, Leib SL, Shalev I, Levy G, Lu X, Lin R, Wen H, Gottstein B. Wang J, et al. PLoS Negl Trop Dis. 2015 May 8;9(5):e0003755. doi: 10.1371/journal.pntd.0003755. eCollection 2015 May. PLoS Negl Trop Dis. 2015. PMID: 25955764 Free PMC article.
The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.
Urbanellis P, Shyu W, Khattar R, Wang J, Zakharova A, He W, Sadozai H, Amir AZ, Shalev I, Phillips MJ, Adeyi O, Ross H, Grant D, Levy GA, Chruscinski A. Urbanellis P, et al. Immunology. 2015 Jan;144(1):91-106. doi: 10.1111/imm.12354. Immunology. 2015. PMID: 24990517 Free PMC article.
Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
Khattar R, Luft O, Yavorska N, Shalev I, Phillips MJ, Adeyi O, Gao D, Bartczak A, Urbanellis P, Shyu W, Zhang J, Manuel J, Levy GA, Selzner N. Khattar R, et al. PLoS One. 2013 Oct 11;8(10):e72309. doi: 10.1371/journal.pone.0072309. eCollection 2013. PLoS One. 2013. PMID: 24146739 Free PMC article.
71 results